+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Biosurgery Market 2021-2028

  • ID: 4774756
  • Report
  • July 2021
  • Region: Global
  • 201 Pages
  • Triton Market Research

FEATURED COMPANIES

  • B Braun Melsungen AG
  • Baxter International Inc
  • Csl Limited
  • Medtronic plc
  • Rti Surgical
  • Sanofi

MARKET OUTLOOK

According to the publisher’s report, the global biosurgery market is anticipated to display growth at a CAGR of 6.21% through the projected period of 2021-2028.
Over the years, technological advancements and innovations in healthcare facilities have resulted in the rise in biosurgery across various nations. Here, biosurgery plays a vital role as an alternative to conventional open surgery. Hence, technological advancements, in addition to the rising geriatric population, are estimated to widen the scope and growth of the biosurgery market over the coming years.

However, the high cost of surgeries, coupled with complications relating to immune response, are significant factors that weigh down the progression of the biosurgery market globally.

REGIONAL OUTLOOK

The global biosurgery market covers North America, Latin America, Asia-Pacific, Europe, and the Middle East and Africa regions.
Globally, the Asia-Pacific is estimated to become the fastest-growing region in the biosurgery market over the forecast period. The region’s strong growth can be attributed to various factors, such as the growing burden of chronic diseases, the rising number of surgical procedures, and the development of new products. Furthermore, the prevalence of various lifestyle conditions and the increasing geriatric population are another set of factors expected to augment the demand for biosurgery products, thereby driving the biosurgery market on a growth path.

COMPETITIVE OUTLOOK

The distinguished companies in the biosurgery market include B Braun Melsungen AG, CSL Limited, Medtronic Plc, Smith & Nephew Plc, Zimmer Biomet Holdings Inc, Becton, Dickinson And Company, Integra Lifesciences Holdings Corporation, RTI Surgical, Ethicon Inc (Johnson & Johnson), Stryker Corporation, Wright Medical Group NV, Baxter International Inc, and Sanofi.
Becton, Dickinson and Company is a global medical technology company involved in developing, manufacturing, and selling medical devices, lab equipment, and diagnostic products. Its product portfolio includes syringes and pen needles, infusion pumps, hemostats, and other products. The company offers its products to life science researchers, healthcare institutes, clinical labs, and pharmaceutical companies. It has operations across various regions, including Asia-Pacific and Europe, with headquarters in the United States.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B Braun Melsungen AG
  • Baxter International Inc
  • Csl Limited
  • Medtronic plc
  • Rti Surgical
  • Sanofi

1. Global Biosurgery Market - Summary
2. Industry Outlook
2.1. Impact of COVID-19 on Biosurgery Market
2.2. Trends in Biosurgery Technology
2.3. Key Insights
2.4. Porter's Five Forces Model
2.4.1. Threat of New Entrants
2.4.2. Threat of Substitute Products
2.4.3. Bargaining Power of Buyers
2.4.4. Bargaining Power of Suppliers
2.4.5. Competitive Rivalry
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Key Buying Outlook
2.8. Key Market Strategies
2.8.1. Contracts and Partnerships
2.8.2. Business Expansions, Announcements, & Divestitures
2.8.3. Acquisitions & Mergers
2.8.4. New Product Launches & Developments
2.9. Market Drivers
2.9.1. Growing Aging Population
2.9.2. Technological Advancements and Innovations in Healthcare Facilities
2.9.3. Surge in Surgical Treatments for Musculoskeletal Disorders
2.9.4. Prevalence of Spinal Fusion and Joint Reconstruction
2.9.5. Strong Focus on Research and Development
2.10. Market Challenges
2.10.1. High Cost of Surgeries
2.10.2. Complications Related to Immune Response
2.10.3. Usage of Minimally Invasive Surgeries
2.11. Market Opportunities
2.11.1. Research and Investments in Bioengineering
2.11.2. Development of Policies for Reimbursement and Compensation
3. Global Biosurgery Market - by Product
3.1. Hemostatic Agents
3.2. Bone-Graft Substitutes
3.2.1. Synthetic Graft Extenders
3.2.2. Demineralized Bone Matrix
3.2.3. Bone Morphogenetic Proteins
3.2.4. Cell-Based Matrices
3.3. Surgical Sealing Agents
3.3.1. Natural
3.3.2. Synthetic
3.4. Soft-Tissue Management
3.4.1. Synthetic Mesh/Patch
3.4.2. Natural Mesh/Patch
3.5. Anti-Adhesive Agents
3.6. Staple Line Reinforcement
4. Global Biosurgery Market - by Application
4.1. Orthopedic Surgery
4.2. Cardio and Thoracic Surgery
4.3. Neuro and Spine Surgery
4.4. General Surgery
4.5. Other Applications
5. Global Biosurgery Market - by Source Type
5.1. Natural
5.2. Synthetic
6. Global Biosurgery Market - Regional Outlook
6.1. North America
6.1.1. Market by Product
6.1.1.1. Bone-Graft Substitutes Market by Type
6.1.1.2. Surgical Sealing Agents Market by Type
6.1.1.3. Soft-Tissue Management Market by Type
6.1.2. Market by Application
6.1.3. Market by Source Type
6.1.4. Country Analysis
6.1.4.1. United States
6.1.4.2. Canada
6.2. Europe
6.2.1. Market by Product
6.2.1.1. Bone-Graft Substitutes Market by Type
6.2.1.2. Surgical Sealing Agents Market by Type
6.2.1.3. Soft-Tissue Management Market by Type
6.2.2. Market by Application
6.2.3. Market by Source Type
6.2.4. Country Analysis
6.2.4.1. Germany
6.2.4.2. United Kingdom
6.2.4.3. France
6.2.4.4. Italy
6.2.4.5. Spain
6.2.4.6. Russia
6.2.4.7. Rest of Europe
6.3. Asia-Pacific
6.3.1. Market by Product
6.3.1.1. Bone-Graft Substitutes Market by Type
6.3.1.2. Surgical Sealing Agents Market by Type
6.3.1.3. Soft-Tissue Management Market by Type
6.3.2. Market by Application
6.3.3. Market by Source Type
6.3.4. Country Analysis
6.3.4.1. China
6.3.4.2. Japan
6.3.4.3. India
6.3.4.4. Australia & New Zealand
6.3.4.5. South Korea
6.3.4.6. Asean Countries
6.3.4.7. Rest of Asia-Pacific
6.4. Latin America
6.4.1. Market by Product
6.4.1.1. Bone-Graft Substitutes Market by Type
6.4.1.2. Surgical Sealing Agents Market by Type
6.4.1.3. Soft-Tissue Management Market by Type
6.4.2. Market by Application
6.4.3. Market by Source Type
6.4.4. Country Analysis
6.4.4.1. Brazil
6.4.4.2. Mexico
6.4.4.3. Rest of Latin America
6.5. Middle East and Africa
6.5.1. Market by Product
6.5.1.1. Bone-Graft Substitutes Market by Type
6.5.1.2. Surgical Sealing Agents Market by Type
6.5.1.3. Soft-Tissue Management Market by Type
6.5.2. Market by Application
6.5.3. Market by Source Type
6.5.4. Country Analysis
6.5.4.1. Saudi Arabia
6.5.4.2. United Arab Emirates
6.5.4.3. Turkey
6.5.4.4. South Africa
6.5.4.5. Rest of Middle East & Africa
7. Competitive Landscape
7.1. Baxter International Inc
7.2. Becton, Dickinson and Company
7.3. B Braun Melsungen AG
7.4. Csl Limited
7.5. Ethicon Inc (Johnson & Johnson)
7.6. Integra Lifesciences Holdings Corporation
7.7. Medtronic plc
7.8. Rti Surgical
7.9. Sanofi
7.10. Smith & Nephew plc
7.11. Stryker Corporation
7.12. Wright Medical Group Nv
7.13. Zimmer Biomet Holdings Inc
8. Research Methodology & Scope
8.1. Research Scope & Deliverables
8.1.1. Objectives of Study
8.1.2. Scope of Study
8.2. Sources of Data
8.2.1. Primary Data Sources
8.2.2. Secondary Data Sources
8.3. Research Methodology
8.3.1. Evaluation of Proposed Market
8.3.2. Identification of Data Sources
8.3.3. Assessment of Market Determinants
8.3.4. Data Collection
8.3.5. Data Validation & Analysis
List of Tables
Table 1: Global Biosurgery Market, Regional Outlook, 2021-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Contracts and Partnerships
Table 4: Business Expansions, Announcements, & Divestitures
Table 5: Acquisitions & Mergers
Table 6: New Product Launches & Developments
Table 7: Aging Population Around the World 2019 & 2050
Table 8: Global Biosurgery Market, by Product, 2021-2028 (In $ Million)
Table 9: Global Bone-Graft Substitutes Market, by Type, 2021-2028 (In $ Million)
Table 10: Global Surgical Sealing Agents Market, by Type, 2021-2028 (In $ Million)
Table 11: Global Soft-Tissue Management Market, by Type, 2021-2028 (In $ Million)
Table 12: Global Biosurgery Market, by Application, 2021-2028 (In $ Million)
Table 13: Global Biosurgery Market, by Source Type, 2021-2028 (In $ Million)
Table 14: Global Biosurgery Market, Regional Outlook, 2021-2028 (In $ Million)
Table 15: North America Biosurgery Market, Country Outlook, 2021-2028 (In $ Million)
Table 16: North America Biosurgery Market, by Product, 2021-2028 (In $ Million)
Table 17: North America Bone-Graft Substitutes Market, by Type, 2021-2028 (In $ Million)
Table 18: North America Surgical Sealing Agents Market, by Type, 2021-2028 (In $ Million)
Table 19: North America Soft-Tissue Management Market, by Type, 2021-2028 (In $ Million)
Table 20: North America Biosurgery Market, by Application, 2021-2028 (In $ Million)
Table 21: North America Biosurgery Market, by Source Type, 2021-2028 (In $ Million)
Table 22: Europe Biosurgery Market, Country Outlook, 2021-2028 (In $ Million)
Table 23: Europe Biosurgery Market, by Product, 2021-2028 (In $ Million)
Table 24: Europe Bone-Graft Substitutes Market, by Type, 2021-2028 (In $ Million)
Table 25: Europe Surgical Sealing Agents Market, by Type, 2021-2028 (In $ Million)
Table 26: Europe Soft-Tissue Management Market, by Type, 2021-2028 (In $ Million)
Table 27: Europe Biosurgery Market, by Application, 2021-2028 (In $ Million)
Table 28: Europe Biosurgery Market, by Source Type, 2021-2028 (In $ Million)
Table 29: Asia-Pacific Biosurgery Market, Country Outlook, 2021-2028 (In $ Million)
Table 30: Asia-Pacific Biosurgery Market, by Product, 2021-2028 (In $ Million)
Table 31: Asia-Pacific Bone-Graft Substitutes Market, by Type, 2021-2028 (In $ Million)
Table 32: Asia-Pacific Surgical Sealing Agents Market, by Type, 2021-2028 (In $ Million)
Table 33: Asia-Pacific Soft-Tissue Management Market, by Type, 2021-2028 (In $ Million)
Table 34: Asia-Pacific Biosurgery Market, by Application, 2021-2028 (In $ Million)
Table 35: Asia-Pacific Biosurgery Market, by Source Type, 2021-2028 (In $ Million)
Table 36: Latin America Biosurgery Market, Country Outlook, 2021-2028 (In $ Million)
Table 37: Latin America Biosurgery Market, by Product, 2021-2028 (In $ Million)
Table 38: Latin America Bone-Graft Substitutes Market, by Type, 2021-2028 (In $ Million)
Table 39: Latin America Surgical Sealing Agents Market, by Type, 2021-2028 (In $ Million)
Table 40: Latin America Soft-Tissue Management Market, by Type, 2021-2028 (In $ Million)
Table 41: Latin America Biosurgery Market, by Application, 2021-2028 (In $ Million)
Table 42: Latin America Biosurgery Market, by Source Type, 2021-2028 (In $ Million)
Table 43: Middle East and Africa Biosurgery Market, by Product, 2021-2028 (In $ Million)
Table 44: Middle East and Africa Bone-Graft Substitutes Market, by Type, 2021-2028 (In $ Million)
Table 45: Middle East and Africa Surgical Sealing Agents Market, by Type, 2021-2028 (In $ Million)
Table 46: Middle East and Africa Soft-Tissue Management Market, by Type, 2021-2028 (In $ Million)
Table 47: Middle East and Africa Biosurgery Market, by Application, 2021-2028 (In $ Million)
Table 48: Middle East and Africa Biosurgery Market, by Source Type, 2021-2028 (In $ Million)
List of Figures
Figure 1: Global Biosurgery Market 2021-2028 (In $ Million)
Figure 2: Global Biosurgery Market, by Product, 2020 & 2028 (In%)
Figure 3: Global Biosurgery Market, by Hemostatic Agents, 2021-2028 (In $ Million)
Figure 4: Global Biosurgery Market, by Bone-Graft Substitutes, 2021-2028 (In $ Million)
Figure 5: Global Bone-Graft Substitutes Market, by Synthetic Graft Extenders, 2021-2028 (In $ Million)
Figure 6: Global Bone-Graft Substitutes Market, by Demineralized Bone Matrix, 2021-2028 (In $ Million)
Figure 7: Global Bone-Graft Substitutes Market, by Bone Morphogenetic Proteins, 2021-2028 (In $ Million)
Figure 8: Global Bone-Graft Substitutes Market, by Cell-Based Matrices, 2021-2028 (In $ Million)
Figure 9: Global Biosurgery Market, by Surgical Sealing Agents, 2021-2028 (In $ Million)
Figure 10: Global Surgical Sealing Agents Market, by Natural, 2021-2028 (In $ Million)
Figure 11: Global Surgical Sealing Agents Market, by Synthetic, 2021-2028 (In $ Million)
Figure 12: Global Biosurgery Market, by Soft-Tissue Management, 2021-2028 (In $ Million)
Figure 13: Global Soft-Tissue Management Market, by Synthetic Mesh/Patch, 2021-2028 (In $ Million)
Figure 14: Global Soft-Tissue Management Market, by Natural Mesh/Patch, 2021-2028 (In $ Million)
Figure 15: Global Biosurgery Market, by Anti-Adhesive Agents, 2021-2028 (In $ Million)
Figure 16: Global Biosurgery Market, by Staple Line Reinforcement, 2021-2028 (In $ Million)
Figure 17: Global Biosurgery Market, by Application, 2020 & 2028 (In%)
Figure 18: Global Biosurgery Market, by Orthopedic Surgery, 2021-2028 (In $ Million)
Figure 19: Global Biosurgery Market, by Cardio and Thoracic Surgery, 2021-2028 (In $ Million)
Figure 20: Global Biosurgery Market, by Neuro and Spine Surgery, 2021-2028 (In $ Million)
Figure 21: Global Biosurgery Market, by General Surgery, 2021-2028 (In $ Million)
Figure 22: Global Biosurgery Market, by Other Applications, 2021-2028 (In $ Million)
Figure 23: Global Biosurgery Market, by Source Type, 2020 & 2028 (In%)
Figure 24: Global Biosurgery Market, by Natural, 2021-2028 (In $ Million)
Figure 25: Global Biosurgery Market, by Synthetic, 2021-2028 (In $ Million)
Figure 26: United States Biosurgery Market 2021-2028 (In $ Million)
Figure 27: Canada Biosurgery Market 2021-2028 (In $ Million)
Figure 28: Germany Biosurgery Market 2021-2028 (In $ Million)
Figure 29: United Kingdom Biosurgery Market 2021-2028 (In $ Million)
Figure 30: France Biosurgery Market 2021-2028 (In $ Million)
Figure 31: Italy Biosurgery Market 2021-2028 (In $ Million)
Figure 32: Spain Biosurgery Market 2021-2028 (In $ Million)
Figure 33: Russia Biosurgery Market 2021-2028 (In $ Million)
Figure 34: Rest of Europe Biosurgery Market 2021-2028 (In $ Million)
Figure 35: China Biosurgery Market 2021-2028 (In $ Million)
Figure 36: Japan Biosurgery Market 2021-2028 (In $ Million)
Figure 37: India Biosurgery Market 2021-2028 (In $ Million)
Figure 38: Australia & New Zealand Biosurgery Market 2021-2028 (In $ Million)
Figure 39: South Korea Biosurgery Market 2021-2028 (In $ Million)
Figure 40: Asean Countries Biosurgery Market 2021-2028 (In $ Million)
Figure 41: Rest of Asia-Pacific Biosurgery Market 2021-2028 (In $ Million)
Figure 42: Brazil Biosurgery Market 2021-2028 ($ Million)
Figure 43: Mexico Biosurgery Market 2021-2028 ($ Million)
Figure 44: Rest of Latin America Biosurgery Market 2021-2028 ($ Million)
Figure 45: Saudi Arabia Biosurgery Market 2021-2028 (In $ Million)
Figure 46: United Arab Emirates Biosurgery Market 2021-2028 (In $ Million)
Figure 47: Turkey Biosurgery Market 2021-2028 (In $ Million)
Figure 48: South Africa Biosurgery Market 2021-2028 (In $ Million)
Figure 49: Rest of Middle East & Africa Biosurgery Market 2021-2028 (In $ Million)
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Baxter International Inc
  • Becton, Dickinson and Company
  • B Braun Melsungen AG
  • Csl Limited
  • Ethicon Inc (Johnson & Johnson)
  • Integra Lifesciences Holdings Corporation
  • Medtronic plc
  • Rti Surgical
  • Sanofi
  • Smith & Nephew plc
  • Stryker Corporation
  • Wright Medical Group Nv
  • Zimmer Biomet Holdings Inc
Note: Product cover images may vary from those shown

Loading
LOADING...